Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
Sharma A, Ren X, Rosato A, Sangiolo D, Wang Z, Tettamanti S, Zhang Y, Rettinger E, Fenix KA, Sommaggio R, Cappuzzello E, Schmidt-Wolf IGH. Sharma A, et al. Among authors: tettamanti s. Cancer Immunol Immunother. 2024 Jan 27;73(2):21. doi: 10.1007/s00262-023-03605-1. Cancer Immunol Immunother. 2024. PMID: 38279995 Free PMC article.
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.
Magnani CF, Mezzanotte C, Cappuzzello C, Bardini M, Tettamanti S, Fazio G, Cooper LJN, Dastoli G, Cazzaniga G, Biondi A, Biagi E. Magnani CF, et al. Among authors: tettamanti s. Hum Gene Ther. 2018 May;29(5):602-613. doi: 10.1089/hum.2017.207. Epub 2018 Apr 16. Hum Gene Ther. 2018. PMID: 29641322
CARs are sharpening their weapons.
Pievani A, Biondi M, Tettamanti S, Biondi A, Dotti G, Serafini M. Pievani A, et al. Among authors: tettamanti s. J Immunother Cancer. 2024 Jan 31;12(1):e008275. doi: 10.1136/jitc-2023-008275. J Immunother Cancer. 2024. PMID: 38296592 Free PMC article. No abstract available.
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Rotiroti MC, Buracchi C, Arcangeli S, Galimberti S, Valsecchi MG, Perriello VM, Rasko T, Alberti G, Magnani CF, Cappuzzello C, Lundberg F, Pande A, Dastoli G, Introna M, Serafini M, Biagi E, Izsvák Z, Biondi A, Tettamanti S. Rotiroti MC, et al. Among authors: tettamanti s. Mol Ther. 2020 Sep 2;28(9):1974-1986. doi: 10.1016/j.ymthe.2020.05.021. Epub 2020 May 30. Mol Ther. 2020. PMID: 32526203 Free PMC article.
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden.
Biondi M, Tettamanti S, Galimberti S, Cerina B, Tomasoni C, Piazza R, Donsante S, Bido S, Perriello VM, Broccoli V, Doni A, Dazzi F, Mantovani A, Dotti G, Biondi A, Pievani A, Serafini M. Biondi M, et al. Among authors: tettamanti s. Blood. 2023 May 25;141(21):2587-2598. doi: 10.1182/blood.2022018330. Blood. 2023. PMID: 36787509 Free PMC article.
32 results